These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35882204)

  • 1. Zelquistinel Is an Orally Bioavailable Novel NMDA Receptor Allosteric Modulator That Exhibits Rapid and Sustained Antidepressant-Like Effects.
    Burgdorf JS; Zhang XL; Stanton PK; Moskal JR; Donello JE
    Int J Neuropsychopharmacol; 2022 Dec; 25(12):979-991. PubMed ID: 35882204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-Like Growth Factor I Produces an Antidepressant-Like Effect and Elicits N-Methyl-D-Aspartate Receptor Independent Long-Term Potentiation of Synaptic Transmission in Medial Prefrontal Cortex and Hippocampus.
    Burgdorf J; Zhang XL; Colechio EM; Ghoreishi-Haack N; Gross A; Kroes RA; Stanton PK; Moskal JR
    Int J Neuropsychopharmacol; 2015 Sep; 19(2):. PubMed ID: 26374350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive N-Methyl-D-Aspartate Receptor Modulation by Rapastinel Promotes Rapid and Sustained Antidepressant-Like Effects.
    Donello JE; Banerjee P; Li YX; Guo YX; Yoshitake T; Zhang XL; Miry O; Kehr J; Stanton PK; Gross AL; Burgdorf JS; Kroes RA; Moskal JR
    Int J Neuropsychopharmacol; 2019 Mar; 22(3):247-259. PubMed ID: 30544218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long-lasting antidepressant effects of rapastinel (GLYX-13) are associated with a metaplasticity process in the medial prefrontal cortex and hippocampus.
    Burgdorf J; Zhang XL; Weiss C; Gross A; Boikess SR; Kroes RA; Khan MA; Burch RM; Rex CS; Disterhoft JF; Stanton PK; Moskal JR
    Neuroscience; 2015 Nov; 308():202-11. PubMed ID: 26343295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive modulation of NMDA receptors by AGN-241751 exerts rapid antidepressant-like effects via excitatory neurons.
    Pothula S; Liu RJ; Wu M; Sliby AN; Picciotto MR; Banerjee P; Duman RS
    Neuropsychopharmacology; 2021 Mar; 46(4):799-808. PubMed ID: 33059355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMDA Receptor Activation-Dependent Antidepressant-Relevant Behavioral and Synaptic Actions of Ketamine.
    Zanos P; Brown KA; Georgiou P; Yuan P; Zarate CA; Thompson SM; Gould TD
    J Neurosci; 2023 Feb; 43(6):1038-1050. PubMed ID: 36596696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ifenprodil rapidly ameliorates depressive-like behaviors, activates mTOR signaling and modulates proinflammatory cytokines in the hippocampus of CUMS rats.
    Yao Y; Ju P; Liu H; Wu X; Niu Z; Zhu Y; Zhang C; Fang Y
    Psychopharmacology (Berl); 2020 May; 237(5):1421-1433. PubMed ID: 32130432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The NMDA receptor modulator zelquistinel durably relieves behavioral deficits in three mouse models of autism spectrum disorder.
    Fonteneau M; Brugoux A; Jaccaz D; Donello JE; Banerjee P; Le Merrer J; Becker JA
    Neuropharmacology; 2024 May; 248():109889. PubMed ID: 38401792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects.
    Burgdorf J; Zhang XL; Nicholson KL; Balster RL; Leander JD; Stanton PK; Gross AL; Kroes RA; Moskal JR
    Neuropsychopharmacology; 2013 Apr; 38(5):729-42. PubMed ID: 23303054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does increasing the ratio of AMPA-to-NMDA receptor mediated neurotransmission engender antidepressant action? Studies in the mouse forced swim and tail suspension tests.
    Andreasen JT; Gynther M; Rygaard A; Bøgelund T; Nielsen SD; Clausen RP; Mogensen J; Pickering DS
    Neurosci Lett; 2013 Jun; 546():6-10. PubMed ID: 23643996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GM-1020: a novel, orally bioavailable NMDA receptor antagonist with rapid and robust antidepressant-like effects at well-tolerated doses in rodents.
    Klein AK; Austin EW; Cunningham MJ; Dvorak D; Gatti S; Hulls SK; Kiss L; Kruegel AC; Marek GJ; Papp M; Sporn J; Hughes ZA
    Neuropsychopharmacology; 2024 May; 49(6):905-914. PubMed ID: 38177696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice lacking NMDA receptors in parvalbumin neurons display normal depression-related behavior and response to antidepressant action of NMDAR antagonists.
    Pozzi L; Pollak Dorocic I; Wang X; Carlén M; Meletis K
    PLoS One; 2014; 9(1):e83879. PubMed ID: 24454710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of Novel and Potent
    Li Z; Cai G; Fang F; Li W; Fan M; Lian J; Qiu Y; Xu X; Lv X; Li Y; Zheng R; Wang Y; Li Z; Zhang G; Liu Z; Huang Z; Zhang L
    J Med Chem; 2021 May; 64(9):5551-5576. PubMed ID: 33934604
    [No Abstract]   [Full Text] [Related]  

  • 14. A novel NMDA receptor modulator: the antidepressant effect and mechanism of GW043.
    Tiliwaerde M; Gao N; Yang Y; Jin Z
    CNS Neurosci Ther; 2024 Feb; 30(2):e14598. PubMed ID: 38332552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of extracellular signal-regulated kinase (ERK) in the short and long-lasting antidepressant-like activity of NMDA receptor antagonists (zinc and Ro 25-6981) in the forced swim test in rats.
    Pochwat B; Rafało-Ulińska A; Domin H; Misztak P; Nowak G; Szewczyk B
    Neuropharmacology; 2017 Oct; 125():333-342. PubMed ID: 28802646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapastinel (GLYX-13) has therapeutic potential for the treatment of post-traumatic stress disorder: Characterization of a NMDA receptor-mediated metaplasticity process in the medial prefrontal cortex of rats.
    Burgdorf J; Kroes RA; Zhang XL; Gross AL; Schmidt M; Weiss C; Disterhoft JF; Burch RM; Stanton PK; Moskal JR
    Behav Brain Res; 2015 Nov; 294():177-85. PubMed ID: 26210936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAK-653, an AMPA receptor potentiator with minimal agonistic activity, produces an antidepressant-like effect with a favorable safety profile in rats.
    Hara H; Suzuki A; Kunugi A; Tajima Y; Yamada R; Kimura H
    Pharmacol Biochem Behav; 2021 Dec; 211():173289. PubMed ID: 34655652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical Characterization of (
    Bristow LJ; Gulia J; Weed MR; Srikumar BN; Li YW; Graef JD; Naidu PS; Sanmathi C; Aher J; Bastia T; Paschapur M; Kalidindi N; Kumar KV; Molski T; Pieschl R; Fernandes A; Brown JM; Sivarao DV; Newberry K; Bookbinder M; Polino J; Keavy D; Newton A; Shields E; Simmermacher J; Kempson J; Li J; Zhang H; Mathur A; Kallem RR; Sinha M; Ramarao M; Vikramadithyan RK; Thangathirupathy S; Warrier J; Islam I; Bronson JJ; Olson RE; Macor JE; Albright CF; King D; Thompson LA; Marcin LR; Sinz M
    J Pharmacol Exp Ther; 2017 Dec; 363(3):377-393. PubMed ID: 28954811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of STP, LTP and LTD by structurally diverse NMDA receptor subunit-specific positive allosteric modulators.
    France G; Volianskis R; Ingram R; Bannister N; Rothärmel R; Irvine MW; Fang G; Burnell ES; Sapkota K; Costa BM; Chopra DA; Dravid SM; Michael-Titus AT; Monaghan DT; Georgiou J; Bortolotto ZA; Jane DE; Collingridge GL; Volianskis A
    Neuropharmacology; 2022 Jan; 202():108840. PubMed ID: 34678377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant-like effects induced by NMDA receptor blockade and NO synthesis inhibition in the ventral medial prefrontal cortex of rats exposed to the forced swim test.
    Pereira VS; Romano A; Wegener G; Joca SR
    Psychopharmacology (Berl); 2015 Jul; 232(13):2263-73. PubMed ID: 25589143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.